Alzheimer's disease (AD) is a neurodegenerative brain disorder associated with relentlessly
progressive cognitive impairment and memory loss. AD pathology proceeds for decades …

The Cardiovascular Inflammation Reduction Trial (CIRT) was designed to assess whether
low-dose methotrexate (LD-MTX) would reduce future cardiac events in patients with …

Alzheimer disease (AD) is an age-related neurodegenerative disorder that manifests as a
progressive loss of memory and deterioration of higher cognitive functions. Alzheimer disease …

Background Impaired insulin signaling pathway in the brain in type 2 diabetes (T2D) is a risk
factor for Alzheimer disease (AD). Glucagon-like peptide-1 (GLP-1) and its receptor agonist …

Among omics, the proteomics assumes a unique role in that it offers the effectors or actuators
of a biological condition. This brief review attempts to summarize the development in a …

Background: Few studies have compared the accuracy of [ 18 F]fluorodeoxyglucose (FDG)
PET to the accuracy of clinical and pathologic diagnosis in dementia patients. Methods: Forty-…

The purpose of our study was to investigate the protective effects of a natural product—‘curcumin’—
in Alzheimer's disease (AD)-like neurons. Although much research has been done …

Chronic fatigue syndrome (CFS) is characterized as a persistent, debilitating complex disorder
of unknown etiology, whereby patients suffer from extreme fatigue, which often presents …

Membership in the National Association of Women Lawyers has many advantages, among
them, opportunities for continuing legal education, a subscription to the Women Lawyers …

Revised diagnostic criteria for Alzheimer disease (AD) acknowledge a key role of imaging
biomarkers for early diagnosis. Diagnostic accuracy depends on which marker (ie, amyloid …